NR3C1 and temporal arteritis: Braun et al. [39] aimed to determine the value of clinical genetic findings as well as the expression of GR for discriminating between GCA and PMR patients who achieve either complete remission or partial remission after GCs, as opposed to those who are resistant to GC treatment.